Consolidated Statements of Operations (Unaudited) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Revenues, net
Cost of products sold
Gross profit
Operating expenses:
Selling, general and administrative	957,114	1,149,257
Research and development expense	473,528	14,236
Research and development expense	54,308
Total operating expenses	1,484,950	1,163,493
Loss from operations	(1,484,950)	(1,163,493)
Other income (expense):
Gain on issuance of Forte license		3,165,151
Interest expense	(125,607)	(120,403)
Receipt of common shares
Change in market value of common shares		(2,645,000)
(Loss) gain on settlement of obligations and conversion of debt	(40,000)	(1,166,418)
Gain on derivative liability valuation
Charge from warrant modification and debt settlement		(1,605,913)
Total other income (expense)	(165,607)	(2,372,583)
Net (loss) income	$ (1,650,557)	$ (3,536,076)
Basic earnings (loss) per share attributed to common stockholders	$ (0.02)	$ (0.10)
Diluted earnings (loss) per share attributed to common stockholders	$ (0.02)	$ (0.10)
Basic weighted average number of shares outstanding	83,510,001	36,290,359
Diluted weighted average number of shares outstanding	85,129,597	36,290,359